Skip to main content

Media Category: Diagnosis

Thomas Berger: Paramagnetic Rim Lesions and Chronic Inflammation in Multiple Sclerosis

In this short video interview, Thomas Berger explains how insights from neuropathology and advanced MRI have improved our understanding of the long-term evolution of MS lesions. He describes paramagnetic rim lesions as markers of chronic, slowly expanding inflammation driven by microglia and iron accumulation, rather than inactive or “burned-out” scars. Watch the interview What do paramagnetic rim lesions reveal about chronic inflammation and disease progression in multiple sclerosis? In the interview, Thomas Berger focuses on what paramagnetic rim lesions represent biologically...

Continue reading

Šarlota Mesaroš : Central Vein Sign, a Highly Specific MRI Biomarker for Multiple Sclerosis

In this short video interview, Šarlota Mesaroš discusses the role of the central vein sign as an advanced MRI biomarker in multiple sclerosis. While conventional MRI remains central to MS diagnosis, susceptibility-based imaging sequences now allow clinicians to visualize the venous origin of MS lesions. Šarlota highlights how the central vein sign, incorporated into the 2024 McDonald criteria, can support diagnosis and help distinguish MS from mimicking conditions, particularly when diagnostic uncertainty remains. Watch the interview What is the central vein sign, and why is it...

Continue reading

New insights in the 2024 McDonald criteria: imaging biomarkers shaping MS diagnosis

In this keynote lecture at the Belgian MS Symposium 2025, Pietro Maggi discussed how advanced MRI biomarkers have been integrated into the upcoming 2024 revisions of the McDonald diagnostic criteria for Multiple Sclerosis. Key Insights from the Webinar: These revisions aim to improve diagnostic precision and reduce misdiagnosis, particularly in early or atypical cases. Among the most significant updates are: Optic nerve involvement — now recognized as a fifth anatomical location for demonstrating dissemination in space (DIS), supported by MRI, visual evoked potentials (VEP), and...

Continue reading

Translation of 2024 MS criteria for asymptomatic individuals into clinical practice: From RIS to MS

This recording will help you refine your MS diagnostic skills with Christine Lebrun-Frenay led-insights on the 2024 McDonald criteria and practical tools for confident early detection. Key Insights from the Webinar The 2024 McDonald revision refines diagnostic clarity in Multiple Sclerosis (MS) while maintaining strong continuity with the 2017 criteria. The update aims to support earlier, more confident diagnosis, particularly for asymptomatic or preclinical cases, and to reduce over-diagnosis in patients with vascular or migraine-related MRI findings. The session highlights how...

Continue reading

New diagnostic criteria for MS

Curious about what’s new in the 2024 McDonald diagnostic criteria for MS? In this expert-led session, Professors Celia Oreja-Guevara and Bassem Yamout, ParadigMS Experts, walk you through the latest updates, including optic nerve involvement, advanced imaging biomarkers, and refined strategies for diagnosing MS in complex cases.Watch now to stay current and sharpen your clinical practice. “New diagnostic criteria for MS“. Please subscribe to watch. Find out about the speakers: Prof. Celia Oreja-Guevara Prof. Bassem Yamout

Continue reading

Differential Diagnosis in MS, NMO-SD and MOGAD

ABSTRACT In the past 20 years, the concept of antibody mediated demyelinating disorders have emerged. These diseases, namely Aquaporin-4 (AQP4) positive neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte (MOG)- antibody associated disease (MOGAD), share common features with multiple sclerosis, but are fundamentally different in terms of pathophysiology, disease course and treatment. In this lecture we will provide a clinical, biological and imaging description of these two entities, and propose a focus on the features that helps to differentiate in between...

Continue reading

FAQs

Is ParadigMS for free?

Yes, a ParadigMS subscription is free for healthcare practitioniers. 

Do subscriptions auto-renew?
Your subscription will automatically renew on yearly basis. If you cancel your plan, it will not renew at the end of your subscription cycle. 
I am a representative from industry, can I subscribe?

Free subscriptions to ParadigMS are reserved for healthcare practitioners. If you are a representative of the industry please contact us on learning@paradigms.foundation and we would advise you how to get the access to the material. 

What happens if I subscribe as a HCP if I am not?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, we will cancel your subscription immediately. 
I am a patient, can I subscribe?

ParadigMS is designed specifically for healthcare practitioners, with content and language tailored to their professional needs. While patients cannot subscribe directly, we encourage you to consult your healthcare provider for relevant insights and updates that may benefit you.

Why should I subscribe to ParadigMS's e-platform?

Subscribing to ParadigMS’s e-platform gives you access to up-to-date information and valuable learning materials on multiple sclerosis and NMO, along with expert insights and the latest innovations in the field. It’s an essential resource for staying informed and enhancing your knowledge in MS care.

How can I cancel my subscription?
You can cancel your subscription in your account settings. 
Can I financially support ParadigMS?

Yes, you can financially support ParadigMS! We welcome donations to help us continue our mission of advancing multiple sclerosis education and research. Your contribution directly supports the creation of educational resources, expert discussions, and innovative projects in MS care. Visit our donation page to learn more about how you can make a difference: ParadigMS Donate.